Factors associated with transfusion requirements during treatment for acute myelogenous leukemia G. FavreM. FoppA. Gratwohl Original Article Pages: 153 - 160
Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia O. G. OttmannA. GanserD. Hoelzer Original Article Pages: 161 - 167
Effect of recombinant human erythropoietin after allogeneic bone marrow transplantation H. LinkT. BruneH. Heinrichs Original Article Pages: 169 - 173
The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma J. M. M. RaemaekersG. W. van ImhoffW. E. Fibbe Original Article Pages: 175 - 181
Serum erythropoietin levels in thalassemia intermedia F. DoreS. BonfigliM. Longinotti Original Article Pages: 183 - 186
Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: A report from the international agranulocytosis and aplastic anemia study M. LevyJ. P. KellyS. Shapiro Original Article Pages: 187 - 190
The acute infection-associated hemolytic anemia of childhood: Immunofluorescent detection of microbial antigens altering the erythrocyte membrane R. -C. SeitzG. BuschermöhleH. H. Hellwege Original Article Pages: 191 - 196
GPI Mount Scopus — a variant of glucosephosphate isomerase deficiency O. ShalevR. S. ShalevE. Beutler Case Report Pages: 197 - 200
Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor M. KatohK. ShikoshiT. Shirai Letter to the Editors Pages: 201 - 202
